The market expects Amedisys (AMED) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...

UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...

Eden Prairie-based health care giant says Amedisys acquisition would boost efficiency, innovation and quality in hospice, ...

Two whistleblowers have adequately alleged that Amedisys Inc. violated the False Claims Act by improperly billing Medicare and other federal health-care programs for home health services, a New York ...

BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the ...

In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price ...

Amedisys Inc is a provider of home health services to the chronic, co-morbid, aging American population. The company's operations include servicing patients through its segments home health, hospice ...

Amedisys Price Performance NASDAQ AMED opened at $92.61 on Tuesday. The company has a 50 day moving average price of $89.23 and a two-hundred day moving average price of $94.12. Amedisys, Inc. has ...

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month ...

Amedisys Stock Up 0.2 % Shares of Amedisys stock opened at $92.80 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a ...